You are on page 1of 1

An initial investigation by the Competition and Markets Authority (CMA) has found UnitedHealth’s

£1.2bn deal to buy EMIS could reduce competition leading to worse outcomes for the NHS and
ultimately patients and UK taxpayers.

You might also like